| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2018 | CPIX Cumberland Pharmaceuticals Inc | Bonner Michael | Chief Financial Officer | Buy | 400 | $6.12 | $2,448.00 | +2.3% | |
| May 17, 2018 | CANN Trees Corp (colorado) | Whitson Shelly | Chief Administrative Officer | Sell | 20,000 | $3.75 | $74,921.50 | -52.7% | |
| May 17, 2018 | PRGO Perrigo Co Plc | Smith Jeffrey C64 | Director | Buy | 400,000 | $75.45 | $30,179,268.38 | +1.6% | |
| May 16, 2018 | AMPH Amphastar Pharmaceuticals, Inc. | Zhang Jack Y.45 | CEO &Chief Scientific Officer | Buy | 40,000 | $16.07 | $642,823.50 | +1.0% | |
| May 16, 2018 | ANIP Ani Pharmaceuticals Inc | Marshbanks Tracy | Director | Sell | 38,236 | $62.33 | $2,383,192.70 | -3.3% | |
| May 15, 2018 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 7,868 | $57.93 | $455,758.62 | -34.4% | |
| May 15, 2018 | PBH Prestige Consumer Healthcare Inc. | Boyko Jean A | SVP, Science And Technology | Sell | 20,528 | $36.91 | $757,688.48 | -64.9% | |
| May 15, 2018 | ALKS Alkermes Plc. | Pops Richard F57 | Director And CEO, Alkermes Plc | Sell | 50,000 | $46.38 | $2,319,100.00 | -7.0% | |
| May 15, 2018 | MRK Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | Sell | 9,972 | $59.66 | $594,963.42 | -17.9% | |
| May 15, 2018 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 25,000 | $33.79 | $844,781.10 | -10.9% | |
| May 15, 2018 | BHC Bausch Health Companies Inc. | De Schutter Richard U | Director | Buy | 15,000 | $21.83 | $327,450.00 | +12.7% | |
| May 15, 2018 | BHC Bausch Health Companies Inc. | De Schutter Richard U | Director | Buy | 10,000 | $21.80 | $218,000.00 | New | |
| May 11, 2018 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 19,550 | $10.06 | $196,673.00 | -0.9% | |
| May 11, 2018 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 140,000 | $81.97 | $11,475,940.00 | -0.1% | |
| May 11, 2018 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 67,132 | $53.11 | $3,565,712.55 | -62.7% | |
| May 10, 2018 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Chairman, President And CEO | Sell | 7,100 | $26.21 | $186,100.00 | -0.7% | |
| May 10, 2018 | ANIP Ani Pharmaceuticals Inc | Marshbanks Tracy | Director | Sell | 62,431 | $62.07 | $3,874,950.62 | -4.8% | |
| May 10, 2018 | TEVA Teva Pharmaceutical Industries Ltd | Mignone Roberto | Director | Buy | 750,000 | $19.24 | $14,432,850.00 | +37.5% | |
| May 10, 2018 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 73,955 | $10.12 | $748,139.55 | -1.6% | |
| May 9, 2018 | LFCR Lifecore Biomedical, Inc. \de\ | Midyett Ronald Lane | Chief Operations Officer | Sell | 9,239 | $13.36 | $123,433.04 | -13.6% | |
| May 8, 2018 | ALKS Alkermes Plc. | Pops Richard F57 | Director And CEO, Alkermes Plc | Sell | 50,000 | $44.32 | $2,215,774.56 | -3.6% | |
| May 8, 2018 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 42,105 | $10.06 | $423,556.99 | -0.9% | |
| May 7, 2018 | NBIX Neurocrine Biosciences Inc | Nevinny Corinne H | Director | Sell | 5,000 | $83.13 | $415,625.00 | -10.4% | |
| May 4, 2018 | AMRX Amneal Pharmaceuticals, Inc. | Aphc Holdings, LLC | 10% Owner | Sell | 46,849,316 | $18.25 | $855,000,017.00 | -87.2% | |
| May 3, 2018 | LLY Eli Lilly & Co | Simmons Jeffrey N52 | SVP&Pres. Elanco Animal Health | Sell | 9,027 | $78.50 | $708,619.50 | -6.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.